BWA
PRAX icon

Basecamp Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Basecamp Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
32
+8
+33% +$2.53K ﹤0.01% 991
2026
Q1 		$7.73K Buy
24
+8
+50% +$2.48K ﹤0.01% 1087
2025
Q4 		$4.72K Buy
+16
New +$2.98K ﹤0.01% 1159

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Basecamp Wealth Advisors's PRAX Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Praxis Precision Medicines (PRAX) stake by 33% in Q2 2026, buying an estimated $2.53K and bringing the position to 32 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Basecamp Wealth Advisors first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Basecamp Wealth Advisors held 32 shares of Praxis Precision Medicines worth $10.7K as of Q2 2026.
  • Basecamp Wealth Advisors bought 8 Praxis Precision Medicines shares in Q2 2026, an estimated $2.53K.
  • Praxis Precision Medicines made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #991 holding.
  • Basecamp Wealth Advisors first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.